Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15324367 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting A 3 Year Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive Impairment (MCI)
Conditions: Mild Cognitive Impairment;   Dementia
Interventions: Drug: ladostigil hemitartrate;   Drug: Placebo

Indicates status has not been verified in more than two years